Healthcare provider profile · identity verified

Robert Charles Mead, MD

Family Practice · GREEN BAY, WI · NPI 1225013501

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	700	183
Losartan Potassium	Losartan Potassium	541	145
Rosuvastatin Calcium	Rosuvastatin Calcium	536	139
Metoprolol Succinate	Metoprolol Succinate	412	103
Amlodipine Besylate	Amlodipine Besylate	318	83
Simvastatin	Simvastatin	277	76
Metformin Hcl	Metformin Hcl	271	79
Omeprazole	Omeprazole	262	75
Levothyroxine Sodium	Levothyroxine Sodium	216	53
Tamsulosin Hcl	Tamsulosin Hcl	205	54
Pantoprazole Sodium	Pantoprazole Sodium	199	52
Potassium Chloride	Potassium Chloride	182	43
Lisinopril	Lisinopril	181	45
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	181	50
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	161	45
Metformin Hcl Er	Metformin Hcl	148	37
Allopurinol	Allopurinol	140	41
Sertraline Hcl	Sertraline Hcl	134	29
Gabapentin	Gabapentin	133	41
Escitalopram Oxalate	Escitalopram Oxalate	114	32
Trazodone Hcl	Trazodone Hcl	113	40
Pioglitazone Hcl	Pioglitazone Hcl	112	30
Atenolol	Atenolol	111	29
Alfuzosin Hcl Er	Alfuzosin Hcl	110	28
Glimepiride	Glimepiride	106	30
Terazosin Hcl	Terazosin Hcl	102	30
Hydrochlorothiazide	Hydrochlorothiazide	100	25
Valsartan	Valsartan	98	25
Furosemide	Furosemide	97	27
Finasteride	Finasteride	96	24
Xarelto	Rivaroxaban	94	22
Ezetimibe	Ezetimibe	89	24
Meloxicam	Meloxicam	79	26
Fluticasone Propionate	Fluticasone Propionate	78	33
Clopidogrel	Clopidogrel Bisulfate	74	18
Farxiga	Dapagliflozin Propanediol	74	13
Eliquis	Apixaban	73	16
Ipratropium Bromide	Ipratropium Bromide	71	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	69	16
Donepezil Hcl	Donepezil Hcl	69	17
Alendronate Sodium	Alendronate Sodium	68	19
Venlafaxine Hcl Er	Venlafaxine Hcl	66	15
Montelukast Sodium	Montelukast Sodium	63	19
Clonazepam	Clonazepam	60	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	16
Warfarin Sodium	Warfarin Sodium	55	16
Jardiance	Empagliflozin	54	18
Metoprolol Tartrate	Metoprolol Tartrate	54	17
Carvedilol	Carvedilol	53	11
Citalopram Hbr	Citalopram Hydrobromide	52	14
Triamcinolone Acetonide	Triamcinolone Acetonide	52	34
Isosorbide Mononitrate Er	Isosorbide Mononitrate	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	14
Doxazosin Mesylate	Doxazosin Mesylate	48	suppressed
Spironolactone	Spironolactone	48	13
Ozempic	Semaglutide	47	suppressed
Mounjaro	Tirzepatide	46	suppressed
Diclofenac Sodium	Diclofenac Sodium	45	16
Pravastatin Sodium	Pravastatin Sodium	45	12
Trulicity	Dulaglutide	44	11
Mirtazapine	Mirtazapine	43	suppressed
Lovastatin	Lovastatin	40	12
Oxybutynin Chloride Er	Oxybutynin Chloride	40	15
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Azithromycin	Azithromycin	38	38
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Symbicort	Budesonide/Formoterol Fumarate	37	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	suppressed
Propranolol Hcl Er	Propranolol Hcl	36	suppressed
Pregabalin	Pregabalin	34	15
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Bumetanide	Bumetanide	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	suppressed
Atovaquone-Proguanil Hcl	Atovaquone/Proguanil Hcl	29	29
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Glipizide	Glipizide	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Potassium Citrate Er	Potassium Citrate	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Famotidine	Famotidine	22	suppressed
Fosinopril Sodium	Fosinopril Sodium	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	17
Alprazolam	Alprazolam	21	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Prednisone	Prednisone	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Ramipril	Ramipril	19	suppressed
Cholestyramine	Cholestyramine (With Sugar)	18	suppressed
Loperamide	Loperamide Hcl	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Terbinafine Hcl	Terbinafine Hcl	18	11
Estradiol	Estradiol	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Naproxen	Naproxen	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Methimazole	Methimazole	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Amoxicillin	Amoxicillin	15	11
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Single Use Swab	Alcohol Antiseptic Pads	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Galantamine Er	Galantamine Hbr	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error